Iloprost-d4 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Iloprost-d4 is a labelled synthetic analogue of Prostacyclin (PGI2) used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and ischemia. It acts through elevation of cAMP by binding to the prostacyclin receptor (IP receptor). Iloprost inhibits the ADP, thrombin, and collagen-induced aggregation of human platelets with an ED50 of about 13 nM. In whole animals, iloprost acts as a vasodilator, hypotensive, antidiuretic, and prolongs bleeding time.

Iloprost-d4 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Iloprost-d4 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15402	60

---

• Iloprost-d4
• (1S,2R,3R,5S)-7-[(E)-4-Carboxybutylidene]-2-[(3S,1E)-3-hydroxy-4-Methyl-6-octyn-1-enyl]-bicyclo[3.3.0]octane-d4
• (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-Methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]pentanoic Acid-d4
• Ciloprost-d4
• Endoprost-d4
• IloMedin-d4
• ZK 36374-d4
• C22H28D4O4
• Chiral Reagents
• Inhibitors
• Intermediates & Fine Chemicals
• Isotope Labelled Compounds
• Pharmaceuticals